Phase 1 trial of KYAN-001
Latest Information Update: 01 Oct 2020
At a glance
- Drugs KYAN-001 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors KYAN Therapeutics
- 01 Oct 2020 New trial record
- 24 Sep 2020 According to a KYAN Therapeutics media release, the company anticipates advancing KYAN-001 through to Phase I clinical trials by 2022.